Accelerating Drug Development Process at Scale Services
Accelerating Drug Development Process at Scale: Nexelis, a Q² Solutions Company, utilizes automated systems for high throughput through our investment in robotics to support our scientists, who generate over 1.5 million results annually. Our immense capacity helps accelerate the drug discovery and clinical trial process. Controlling for variability when performing manual processes at the order of magnitude required for large sample volume throughput is virtually impossible. However, our investment in automation helps our team to deliver consistently with accuracy, reproducibility, and precision to meet client’s expectations and timelines. Our automated, validated data reporting systems also ensure objectivity when generating results. With state-of-the-art equipment at our facilities globally, our team produces data for large scale projects with increased output for consistent and timely delivery of results.